Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores.

Res Pract Thromb Haemost · 2024 · PMC11564956 · PMID 39552772

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP = .09so close (0.05 < p ≤ 0.1)

IMPEDE-VTE was the only score to successfully differentiate between intermediate-risk (7.14%) and high-risk (13.2%) of VTE at 6 months, although it did not reach statistical significance ( P = .09).

also in 111,027 other papers

showed a trendno p-value reported

Only IMPEDE-VTE showed a trend in differentiating patients at intermediate and high thrombotic risk, yet the incidence of thrombosis is high enough in both groups to require a change in prophylactic strategy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.